Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury

Summary

This study seeks to measure changes in cognition through verbal and visual test procedures and changes in biomarkers of Traumatic Brain Injury and inflammatory and metabolic parameters.

Timeline

Start

2023-12-21

Primary completion

2025-07-21

Completion

2025-07-21

Outcome

Outcome not reported

Stopped: “The study team was informed by the final participant's PCP that the subject discontinued the study medication. The participant's caregiver requested for the participant to be withdrawn from the study. The investigator has decided to close out.”

Drugs

Indications